IFNG and granular corneal dystrophy type II: Thus, our results revealed that α‐melittin‐NP treatment is superior to melittin treatment of ACD in controlling IFN‐γ production and in the safety of intradermal administration, and α‐melittin‐NPs might exert immunoregulatory effects by controlling IFN‐γ secretion.